About this test
This panel utilizes flow cytometry to detect and characterize aberrant lymphoid cell populations in blood samples, aiding in the diagnosis of Acute Lymphoblastic Leukemia. It helps classify the specific subtype of ALL, which is crucial for determining prognosis and guiding treatment decisions. Individuals with symptoms suggestive of leukemia or those undergoing treatment for ALL may consider this test.